ALBO

Albireo Pharma Inc
ALBO

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ALBO was delisted on the 2nd of March, 2023.

Back to rankings

37 hedge funds and large institutions have $11.6M invested in Albireo Pharma Inc in 2014 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

67% less call options, than puts

Call options by funds: $38K | Put options by funds: $116K

Holders
37
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$38K
Puts
$116K
Net Calls
Net Calls Change

Top Buyers

1
+$710K
2
+$520K
3
+$236K
4
Renaissance Technologies
Renaissance Technologies
New York
+$88K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$19.7K

Top Sellers

1
-$1.13M
2
-$914K
3
-$775K
4
FNYS
First New York Securities
New York
-$666K
5
TC
TFS Capital
Pennsylvania
-$494K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$18K
27
$13K
28
$8K
29
$7K
30
$5K
31
$3K
32
$3K
33
$2K
34
$1K
35
$1K
36
$1K
37
–
38
–
39
–
40
–
41
–
42
–
43
–
44
–
45
–
46
–
1
2